Polyclonal Antibodies Market on Track for Strong Growth, Estimated to Grow at 6.9% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Polyclonal Antibodies Market Through 2025?
In recent times, the size of the polyclonal antibodies market has shown steady growth. It's projected to rise from $1.41 billion in 2024 to reach $1.48 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.0%. The growth during the historical period can be credited to the demand for biomedical research, an upsurge in diagnostic uses, a rise in chronic diseases, and a vast array of applications.

What's the Projected Size of the Global Polyclonal Antibodies Market by 2029?
The market for polyclonal antibodies is poised for significant expansion in the upcoming years, anticipated to attain a value of "$1.94 billion in 2029" with a CAGR of 6.9%. This projected growth within the forecast period is largely due to advancements in diagnostic technologies and treatments, a surge in infectious diseases, increased funding for research, and collaboration and partnerships. Key trends within this forecast period encompass progress in antibody engineering, its escalating involvement in cancer immunotherapy, the emergence of biosimilar polyclonal antibodies, its utilisation in neurological disorders, and advancements in regulatory and compliance measures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/polyclonal-antibodies-global-market-report

Top Growth Drivers in the Polyclonal Antibodies Industry: What's Accelerating the Market?
The rise in cancer cases is anticipated to fuel the expansion of the polyclonal antibodies market. In cancer research and treatment, polyclonal antibodies are employed for biomarker discovery, immunohistochemistry, targeted therapy, and immunotherapy, enhancing cancer diagnosis, treatment, and patient outcomes. The surge in cancer patients boosts the polyclonal antibodies market growth. For example, Cancer Australia, an Australian organization dedicated to aiding cancer patients and raising disease awareness, predicts 2,572 new cases of stomach cancer in Australia in 2022 (1,661 cases in men and 911 in women) as of September 2022. The chance of getting stomach cancer by the age of 85 in 2022 is 1 in 114 (0.87%) overall, which breaks down to 1 in 1.1 (87%) for men and 1 in 167 (0.60%) for women. Therefore, the rising prevalence of cancer instigates the growth of the polyclonal antibodies market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10790&type=smp

What Are the Key Trends Driving Polyclonal Antibodies Market Growth?
The primary emerging patterns in the polyclonal antibodies sector involve intensive research and development. To enhance their examination abilities and maintain their market position, key businesses in the field of polyclonal antibodies are heavily focusing on this aspect. As an example, in July 2022, GigaGen Inc., a biotech firm from the United States, publicized a research piece named 'GMP manufacturing and IND-enabling studies of a recombinant hyperimmune globulin targeting SARS-CoV-2,' featured in the globally accredited journal, Pathogens. The research article unveiled its recombinant polyclonal product, GIGA-2050, which targets SARS-CoV-2. It also presented the GMP (good manufacturing practice) production and IND (Investigational Novel Drug)-oriented studies of its innovative category of medicinal products, notably recombinant polyclonal antibodies. GIGA-2050 possesses more than 12,000 antibodies sourced from a single master cell bank (MCB). Prior to GIGA-2050, the production of relatively smaller recombinant antibody mixtures often required building separate MCBs for various monoclonal antibodies and then amalgamating these MCBs before production.

What Are the Main Segments in the Polyclonal Antibodies Market?
The polyclonal antibodies market covered in this report is segmented -

1) By Product Type: Primary Antibody, Secondary Antibody
2) By Source: Rabbits, Goats, Sheep, Other Sources
3) By Application: Research, Diagnostics, Therapy
4) By End-User: Academic and Research Center , Pharmaceutical and Biotechnology Companies, Diagnostic Centers , Hospitals

Subsegments:
1) By Primary Antibody: Immunoglobulin G (IgG), Immunoglobulin M (IgM), Immunoglobulin A (IgA), Immunoglobulin E (IgE)
2) By Secondary Antibody: Anti-Mouse IgG, Anti-Rabbit IgG, Anti-Goat IgG, Other Secondary Antibodies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10790&type=smp

Which Top Companies are Driving Growth in the Polyclonal Antibodies Market?
Major companies operating in the polyclonal antibodies market include Abcam plc, GenScript Biotech Corporation, Merck KGaA, Thermo Fisher Scientific Inc., Becton dic*kinson and Company, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Creative Diagnostics, Agilent Technologies, Analytik Jena GmbH, Atlas Antibodies, Danaher Corporation, DC Biosciences Ltd., Illumia Inc., ImmonoPresice Antibodies Ltd, Fujirebio, Omega BioTek Inc., Dovetail Genomics LLC, Abnova Corporation, Santa Cruz Biotechnology Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., IGY Life Sciences, Genway Biotech, Good Biotech, Gallus Immunotech Inc., BioGenes GmbH, Capralogics Inc., Bio X Cell

Which Regions Will Dominate the Polyclonal Antibodies Market Through 2029?
North America was the largest region in the polyclonal antibodies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global polyclonal antibodies market size forecast period. The regions covered in the polyclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10790

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.